Cite

HARVARD Citation

    Bauss, F. et al. (n.d.). Characterization of a re‐engineered, mesothelin‐targeted Pseudomonas exotoxin fusion protein for lung cancer therapy. Molecular oncology. 10 (8), pp. 1317-1329. [Online]. 
  
Back to record